Handelsbanken Fonder’s Privia Health PRVA Stock Holding History

Handelsbanken Fonder’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$700K	Buy	27,200 +5,500	+25%	+$127K	﹤0.01%	1280
2026 Q1	$446K	Hold	21,700	–	–	﹤0.01%	1329
2025 Q4	$515K	Hold	21,700	–	–	﹤0.01%	1295
2025 Q3	$540K	Hold	21,700	–	–	﹤0.01%	1236
2025 Q2	$499K	Hold	21,700	–	–	﹤0.01%	1252
2025 Q1	$487K	Hold	21,700	–	–	﹤0.01%	1247
2024 Q4	$424K	Hold	21,700	–	–	﹤0.01%	1352
2024 Q3	$395K	Buy	21,700 +3,700	+21%	+$70.6K	﹤0.01%	1331
2024 Q2	$313K	Buy	18,000 +3,000	+20%	+$53.1K	﹤0.01%	1368
2024 Q1	$294K	Hold	15,000	–	–	﹤0.01%	1387
2023 Q4	$345K	Buy	15,000 +4,400	+42%	+$98.5K	﹤0.01%	1327
2023 Q3	$244K	Hold	10,600	–	–	﹤0.01%	1381
2023 Q2	$277K	Buy	10,600 +2,100	+25%	+$55.5K	﹤0.01%	1372
2023 Q1	$235K	Buy	+8,500	New	+$224K	﹤0.01%	1399
2022 Q4	–	Sell	-6,600	Closed	-$225K	–	1596
2022 Q3	$225K	Sell	6,600 -8,200	-55%	-$303K	﹤0.01%	1395
2022 Q2	$431K	Hold	14,800	–	–	﹤0.01%	1108
2022 Q1	$396K	Hold	14,800	–	–	﹤0.01%	1362
2021 Q4	$383K	Buy	+14,800	New	+$369K	﹤0.01%	1518

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Handelsbanken Fonder's PRVA Position: Q2 2026 in Review

Handelsbanken Fonder increased its Privia Health (PRVA) stake by 25% in Q2 2026, buying an estimated $127K and bringing the position to 27,200 shares worth $700K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Handelsbanken Fonder first reported a position in PRVA in Q4 2021 and has held it in 18 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

Handelsbanken Fonder held 27,200 shares of Privia Health worth $700K as of Q2 2026.
Handelsbanken Fonder bought 5,500 Privia Health shares in Q2 2026, an estimated $127K.
Privia Health made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1280 holding.
Handelsbanken Fonder first reported a position in Privia Health in Q4 2021 and has held it in 18 quarters since.
301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.